Literature DB >> 8239758

Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.

C S Lau1, M McLaren, J Hanslip, M Kerr, J J Belch.   

Abstract

OBJECTIVES: (a) To assess plasma fibrinolytic parameters in patients with rheumatoid arthritis (RA) and to determine whether there are differences between patients with RA alone and those with RA complicated by vasculitis. (b) To determine if patients with RA respond differently to venous occlusion compared with normal subjects and to assess whether such a response differs in patients with RA alone and those with rheumatoid vasculitis. (c) To determine the extent of vascular damage in patients with rheumatoid vasculitis and if this correlates with the levels of plasma fibrinolytic parameters.
METHODS: Sixty three patients with RA (38 had RA only and 25 had evidence of rheumatoid vasculitis) were recruited. Plasma levels of tissue plasminogen activator antigen (t-PA Ag), plasminogen activator inhibitor (PAI) activity, and factor VIII von Willebrand factor (vWF) were measured before and 10 minutes after venous occlusion.
RESULTS: Patients with RA, with or without rheumatoid vasculitis, had higher baseline PAI levels than control subjects. The difference was statistically significant for patients with RA alone but was not statistically significant for patients with rheumatoid vasculitis. After venous occlusion, t-PA Ag levels increased significantly in normal subjects and patients with RA alone, but not in patients with rheumatoid vasculitis. Plasma levels of vWF were significantly higher in patients with rheumatoid vasculitis than in normal subjects and those with RA alone. In patients with RA alone, baseline vWF correlated positively with t-PA Ag levels, whereas a negative correlation was found between these two parameters in patients with rheumatoid vasculitis. A negative correlation between vWF and t-PA Ag levels after venous occlusion was also found in patients with rheumatoid vasculitis.
CONCLUSIONS: Patients with rheumatoid vasculitis showed evidence of vascular damage with increased levels of vWF and impaired t-PA Ag release after venous occlusion, a useful measurement of endothelial reserve to remove fibrin. This may be of pathophysiological importance in the development of vasculitis in these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239758      PMCID: PMC1005140          DOI: 10.1136/ard.52.9.643

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  The production of arthritis in rabbits by an immunological reaction to fibrin.

Authors:  D C DUMONDE; L E GLYNN
Journal:  Br J Exp Pathol       Date:  1962-08

2.  Early joint lesions of rheumatoid arthritis; report of eight cases, with knee biopsies of lesions of less than one year's duration.

Authors:  J P KULKA; D BOCKING; M W ROPES; W BAUER
Journal:  AMA Arch Pathol       Date:  1955-02

Review 3.  Vasculitis and ulceration in rheumatic diseases of the foot.

Authors:  M I Cawley
Journal:  Baillieres Clin Rheumatol       Date:  1987-08

Review 4.  Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease.

Authors:  J C Fantone; P A Ward
Journal:  Hum Pathol       Date:  1985-10       Impact factor: 3.466

5.  Synovitis of recent onset. A clinicopathologic study during the first month of disease.

Authors:  H R Schumacher; R C Kitridou
Journal:  Arthritis Rheum       Date:  1972 Sep-Oct

6.  The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.

Authors:  J J Belch; R Madhok; B McArdle; K McLaughlin; C Kluft; C D Forbes; R D Sturrock
Journal:  Q J Med       Date:  1986-01

7.  Coagulation abnormalities in rheumatoid disease.

Authors:  D L Conn; F C McDuffie; F J Kazmier; A L Schroeter; N C Sun
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

8.  Immune complexes in sera from patients with rheumatoid vasculitis induce polymorphonuclear cell-mediated injury to endothelial cells.

Authors:  F C Breedveld; A H Heurkens; G J Lafeber; V W van Hinsbergh; A Cats
Journal:  Clin Immunol Immunopathol       Date:  1988-08

9.  Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor.

Authors:  J J Belch; A R Saniabadi; K McLaughlin; C D Forbes
Journal:  Lipids       Date:  1987-03       Impact factor: 1.880

10.  Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis.

Authors:  H Awada; G Barlowatz-Meimon; M Dougados; P Maisonneuve; Y Sultan; B Amor
Journal:  J Lab Clin Med       Date:  1988-02
View more
  4 in total

Review 1.  The role of endothelial function and its assessment in rheumatoid arthritis.

Authors:  Faisel Khan; Bernat Galarraga; Jill J F Belch
Journal:  Nat Rev Rheumatol       Date:  2010-03-30       Impact factor: 20.543

Review 2.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

3.  Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.

Authors:  Theodoros Dimitroulas; Karen M J Douglas; Vasileios F Panoulas; Tracey Toms; Jacqueline P Smith; Gareth J Treharne; Peter Nightingale; James Hodson; George D Kitas
Journal:  Clin Rheumatol       Date:  2013-05-15       Impact factor: 2.980

4.  Complement-mediated regulation of tissue factor activity in endothelium.

Authors:  S Saadi; R A Holzknecht; C P Patte; D M Stern; J L Platt
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.